🇺🇸 FDA
Patent

US 8491884

Virus clearance of neoplastic cells from mixed cellular compositions

granted A61KA61K35/28A61K35/761

Quick answer

US patent 8491884 (Virus clearance of neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K35/28, A61K35/761, A61K35/768, A61P